Innovent Biologics

Innovent Biologics is a leading biopharmaceutical company dedicated to empowering patients worldwide with affordable, high-quality biopharmaceuticals. Their mission is driven by a commitment to scientific innovation, evidenced by their robust research platform, "Innovent Academy," where world-class scientists discover new drugs and pioneer first-in-class innovations. Innovent boasts a pipeline of 36 innovative drug candidates, with 11 approved products already available in China. Their focus areas include oncology, immunology, cardiovascular diseases, and ophthalmology, with a particular emphasis on developing treatments for unmet medical needs.

Innovent's dedication to responsible practices is reflected in their strong ESG commitments. They prioritize excellence in governance, ensuring high-quality products, empowering employees, and embracing ecology. They are actively engaged in global collaborations, having partnered with over 30 global healthcare companies, including Eli Lilly, Sanofi, and Incyte. Innovent is a leader in the biopharmaceutical industry, demonstrating a strong commitment to scientific innovation, responsible practices, and making a positive impact on the lives of patients worldwide.

Innovent Biologics offers a hybrid working environment, with many of their job postings specifically mentioning that this is the case. This implies a flexible work arrangement, potentially allowing employees to work both remotely and in the office. Further, the company's emphasis on employee well-being and development suggests a supportive culture that may embrace other forms of flexible work arrangements, though this isn't explicitly mentioned on their website.

Innovent Biologics offers a comprehensive compensation package with competitive benefits and incentives. These include medical, vision, and dental insurance, as well as a 401(k) plan. The company also offers stock options to a select group of outstanding employees each year.

Innovent Biologics is a global biopharmaceutical company dedicated to empowering patients worldwide with affordable, high-quality biopharmaceuticals. Their mission is driven by a commitment to scientific innovation, resulting in a pipeline of 36 drug candidates and 11 approved products in China. Innovent strives to be a premier global biopharmaceutical company, pushing the boundaries of science to discover transformative medicines for patients.

Innovent Biologics emphasizes a collaborative and supportive culture that values innovation and employee growth. They promote a dynamic and entrepreneurial work environment, encouraging their employees to take ownership and contribute meaningfully to the company's mission of providing high-quality, affordable biopharmaceuticals to patients worldwide. This is reflected in their commitment to diversity and inclusion, providing comprehensive benefits and incentives, and investing in employee development through their Innovent College platform.

Innovent Biologics is committed to fostering a diverse, equitable, and inclusive workplace. They aim to ensure that the proportion of female employees and executives is not less than 40%, and that the proportion of female candidates for key positions at the time of recruitment is not less than 40%. They offer 100% of employees access to training programs and encourage internal promotions to management positions, emphasizing the importance of talent development and career growth within the company. They have been recognized for their commitment to diversity and inclusion by several organizations, including LinkedIn, Universum, and KING’S ARK.